EU → North America Device Access

The Binding Site Group Ltd

UK-MF-000036707 · United Kingdom · Birmingham

The Binding Site Group Ltd is registered in the European database on medical devices as a manufacturer, with 119 devices declared. It is also registered as a device establishment with the U.S. FDA.

What this manufacturer declares

Most frequent device types declared: IK820, LK001.P, LK016.OPT, LK018.OPT, LK088.OPT.

Authorised representative in the Union: The Binding Site Ireland Limited.

Devices declared under this manufacturer

Showing 12 of 119 declared devices.

Catalogue references include LK016.10.OPT, LK018.10.OPT, MSR801.M, NK006.TB, NK007.TB, NK626.OPT.

European nomenclature codes declared: W0102010106, W0102010109, W0102010107, W0102010105, W0102010101, W0102010102.

United States market access

FDA establishment registerRegistered with FDA
Matched entryThe Binding Site Group Ltd. (GB) · FDA 9614373
Devices in EUDAMED119
Country of registrationUnited Kingdom

Device-level evidence

Devices with a numeric GTIN119
Found in the U.S. device database55
Share46.2 %

Canadian market access

Health Canada licence listingLicensed in Canada
Matched entryTHE BINDING SITE GROUP LIMITED

What it holds in Canada

Licences on record6
Currently active0
Class 2 devices5
Class 3 devices1
First licensed2001-11-06

Licence types: Test Kit (4), System (2).

Licensed under: OPTILITE ANALYSER, EXENT ANALYSER, FREELITE HUMAN KAPPA KITS, FREELITE HUMAN LAMBDA KIT, BINDAZYME ANTI PCP EIA KIT (PNEUMOCOCCAL CAPSU, BINDAZYME HUMAN ANTI HEMOPHILUS INFLUENZA EIA .

North American profile: Both markets. The Binding Site Group Ltd is registered in both the United States and Canada.

Other manufacturers in United Kingdom

All United Kingdom manufacturers →